Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02388958 · ClinicalTrials.gov registry record

Weight Changes During and After Pregnancy in Women With Gestational Diabetes

A clinical trial, sponsored by Vanderbilt University.

Completed
Registry status
89
Enrollment target

NCT02388958: Completed study, sponsored by Vanderbilt University.

NCT02388958 is a clinical trial that has completed, run by Vanderbilt University. The registered enrollment target is 89 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02388958 has completed, sponsored by Vanderbilt University.

COMPLETED
Registry status
89 participants
Enrollment target

Study Summary

Gestational diabetes mellitus (GDM) is associated with short-term and long-term complications for infants and mothers. The management of GDM during pregnancy focuses on reducing risks to the infant associated with hyperglycemia. The postpartum management of GDM focuses on reducing maternal risk of developing type 2 diabetes (T2DM). A diagnosis of GDM identifies up to 31% of parous women who will eventually develop T2DM and approximately 50% of women diagnosed with GDM will develop T2DM in the first 5 years postpartum. The perceived risk of developing short-term and/or long-term complications of GDM may influence women's likelihood of engaging in diet modification, the mainstay of treatment of GDM, both during and after pregnancy. If sustained after delivery, diet modifications introduced as treatment for GDM could affect maternal weight changes during and after pregnancy, which could in turn affect T2DM risk. It is unknown if and how women with GDM differ in their perceived risk of developing T2DM, dietary choices, or weight gain (and retention) during versus after pregnancy. Therefore, the project proposed in this application seeks to (1) characterize the perceived risk of developing T2DM among women with GDM during and after pregnancy, (2) characterize dietary choices of women with GDM during and after pregnancy, and (3) characterize weight changes of women with GDM during and after pregnancy as compared to women without GDM.

Trial Details

FieldValue
Enrollment Target 89 participants
Start Date 2014-06
Est. Completion 2016-12
Vanderbilt University

430 total trials

What the finished NCT02388958 record still lists

NCT02388958 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 89 participants, a relatively small participant target.

The record links to 0 conditions, and to 0 interventions.

NCT02388958 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02388958 about?

NCT02388958 is a clinical study titled "Weight Changes During and After Pregnancy in Women With Gestational Diabetes". Gestational diabetes mellitus (GDM) is associated with short-term and long-term complications for infants and mothers. The management of GDM during pregnancy focuses on reducing risks to the infant associated with hyperglycemia. The postpartum management of GDM focuses on reducing maternal risk of d...

What is the current status of trial NCT02388958?

This trial is currently completed. The enrollment target is 89 participants. The study started on 2014-06. Estimated completion is 2016-12.

Who is sponsoring clinical trial NCT02388958?

This trial is sponsored by Vanderbilt University, which has 430 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03682289 · 89 participants · Phase 2

    Ceralasertib (AZD6738) Alone and in Combination With Olaparib or Durvalumab in Patients With Solid Tumors

  • NCT04787939 · 89 participants · NA

    Early Feeding After Oral Cavity Reconstruction

  • NCT05480449 · 89 participants · Phase 1

    Autologous HuCART19 T Cells Manufactured Using the CliniMACS Prodigy Platform for Pediatric B-ALL (huCART19 Prodigy)

  • NCT05604131 · 89 participants · Phase 2

    Cardiac MRI-guided Deferiprone Therapy for Acute Myocardial Infarction Patients

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02388958, the US trial registry maintained by the National Library of Medicine. NCT02388958 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.